Prevention of TNF-induced necrotic cell death by rottlerin through a Nox1 NADPH oxidase

Hee Sun Byun1, Minho Won, Kyeong Ah Park

  • 1Department of Pharmacology, Research Institute for Medical Science, Infection Signaling Network Research Center, College of Medicine, Chungnam National University, Daejeon 301-131, Korea.

Insights

Rottlerin protects against tumor necrosis factor (TNF)-induced necrosis by inhibiting Nox1 NADPH oxidase. This mechanism, independent of protein kinase C delta (PKC-delta) inhibition, reveals a new target for anti-necrotic therapies.

Area of Science:

  • Cell Biology
  • Molecular Pharmacology
  • Biochemistry

Background:

  • Rottlerin, a protein kinase C delta (PKC-delta) inhibitor, is known to enhance apoptosis via death receptor pathways.
  • The role of rottlerin in regulating necrotic cell death and its underlying mechanisms remain largely unexplored.

Purpose of the Study:

  • To investigate the effect of rottlerin on tumor necrosis factor (TNF)-induced necrosis in murine fibrosarcoma L929 cells.
  • To elucidate the molecular mechanisms by which rottlerin modulates necrotic cell death.

Main Methods:

  • Murine fibrosarcoma L929 cells were treated with rottlerin and/or TNF.
  • Cell death (necrosis and apoptosis) was assessed.
  • Mitochondrial superoxide production, GTP-bound Rac1 activation, and poly(ADP-ribose) polymerase (PARP) activation were measured.

Main Results:

  • Rottlerin protected L929 cells against TNF-induced necrosis.
  • TNF treatment induced mitochondrial superoxide production via Nox1 NADPH oxidase during necrosis.
  • Rottlerin inhibited TNF-induced mitochondrial superoxide production and PARP activation, independent of PKC-delta inhibition.
  • Rottlerin also sensitized cells to apoptosis when co-treated with Hsp90 inhibitor geldanamycin and TNF.

Conclusions:

  • Nox1 NADPH oxidase is a novel molecular target for the anti-necrotic effects of rottlerin.
  • Rottlerin's anti-necrotic activity is mediated by suppressing mitochondrial superoxide production through the inhibition of Nox1 NADPH oxidase.
  • These findings provide new insights into the mechanisms of cell death regulation and potential therapeutic strategies targeting necrosis.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...